Cargando…
The Weight of IgA Anti-β2glycoprotein I in the Antiphospholipid Syndrome Pathogenesis: Closing the Gap of Seronegative Antiphospholipid Syndrome
The specific value of IgA Anti-β2glycoprotein I antibodies (aB2GP1) in the diagnosis and management of antiphospholipid syndrome (APS) is still controversial and a matter of active debate. The relevance of the IgA aB2GP1 isotype in the pathophysiology of APS has been increasingly studied in the last...
Autores principales: | Cabrera-Marante, Oscar, Rodríguez de Frías, Edgard, Serrano, Manuel, Lozano Morillo, Fernando, Naranjo, Laura, Gil-Etayo, Francisco J., Paz-Artal, Estela, Pleguezuelo, Daniel E., Serrano, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730063/ https://www.ncbi.nlm.nih.gov/pubmed/33255963 http://dx.doi.org/10.3390/ijms21238972 |
Ejemplares similares
-
Isolated IgA Anti-β2 Glycoprotein I Antibodies in Patients with Clinical Criteria for Antiphospholipid Syndrome
por: Ruiz-García, Raquel, et al.
Publicado: (2014) -
Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome
por: Cousins, Laura, et al.
Publicado: (2015) -
Immune Complexes of Beta-2-Glycoprotein I and IgA Antiphospholipid Antibodies Identify Patients With Elevated Risk of Thrombosis and Early Mortality After Heart Transplantation
por: Serrano, Manuel, et al.
Publicado: (2019) -
The Mosaic of “Seronegative” Antiphospholipid Syndrome
por: Conti, Fabrizio, et al.
Publicado: (2014) -
Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic Stroke
por: Naranjo, Laura, et al.
Publicado: (2021)